Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis
- PMID: 17805937
- DOI: 10.1007/s11605-007-0282-0
Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis
Abstract
The prognosis of patients with cholangiocarcinoma historically has been poor, even after surgical resection. Although data from some single-institution series indicate improvement over historical results, survival after surgical therapy for cholangiocarcinoma has not been investigated in a population-based study. We used the Surveillance, Epidemiology, and End Results database to identify patients who underwent surgery for cholangiocarcinoma from 1973 through 2002. Multivariate modeling of survival after surgery for intrahepatic cholangiocarcinoma showed an improvement in survival only within the last decade studied, resulting in a cumulative 34.4% improvement in survival from 1992 through 2002. In contrast, multivariate modeling of survival after surgery for extrahepatic cholangiocarcinoma revealed a 23.3% increase in adjusted survival per each decade studied, resulting in a cumulative 53.7% improvement from 1973 through 2002. We conclude that survival after surgery for extrahepatic cholangiocarcinoma has dramatically improved since 1973. Patients with intrahepatic cholangiocarcinoma, however, have achieved an improvement in survival largely confined to more recent years. We suggest that these trends are largely caused by developments in imaging technology, improvements in patient selection, and advances in surgical techniques.
Similar articles
-
Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):189-98. doi: 10.1016/j.ijrobp.2010.05.001. Epub 2010 Oct 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 20971573
-
In favor of the Jarnagin-Blumgart classification.Ann Surg. 2009 Apr;249(4):697-8; author reply 698-9. doi: 10.1097/SLA.0b013e31819f3ba8. Ann Surg. 2009. PMID: 19300209 No abstract available.
-
Influence of marital status on the survival of adults with extrahepatic/intrahepatic cholangiocarcinoma.Oncotarget. 2017 Apr 25;8(17):28959-28970. doi: 10.18632/oncotarget.16330. Oncotarget. 2017. PMID: 28415824 Free PMC article.
-
The current management of hilar cholangiocarcinoma.Adv Surg. 1999;33:345-73. Adv Surg. 1999. PMID: 10572576 Review. No abstract available.
-
What constitutes long-term survival after surgery for hilar cholangiocarcinoma?Cancer. 1997 Jan 1;79(1):26-34. Cancer. 1997. PMID: 8988723 Review.
Cited by
-
Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database.BMC Gastroenterol. 2016 Sep 21;16(1):117. doi: 10.1186/s12876-016-0527-z. BMC Gastroenterol. 2016. PMID: 27655244 Free PMC article.
-
Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.Radiat Oncol J. 2012 Dec;30(4):197-204. doi: 10.3857/roj.2012.30.4.197. Epub 2012 Dec 31. Radiat Oncol J. 2012. PMID: 23346539 Free PMC article.
-
Effect of age on the prognosis of intrahepatic cholangiocarcinoma.Korean J Intern Med. 2023 Jan;38(1):39-47. doi: 10.3904/kjim.2022.146. Epub 2022 Dec 21. Korean J Intern Med. 2023. PMID: 36541019 Free PMC article.
-
Trends in Liver Cancer Incidence and Survival in Italy by Histologic Type, 2003-2017.Cancers (Basel). 2022 Dec 14;14(24):6162. doi: 10.3390/cancers14246162. Cancers (Basel). 2022. PMID: 36551647 Free PMC article.
-
Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?Int J Nanomedicine. 2013;8:4043-4. doi: 10.2147/IJN.S53962. Epub 2013 Oct 23. Int J Nanomedicine. 2013. PMID: 24187496 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical